PPH is categorized as primary PPH if blood loss occurs within 24 hours of delivery and secondary PPH if the blood loss occurs after 24 hours of delivery.
Post-partum hemorrhage (PPH) defined as blood loss after vaginal or cesarean delivery, is the leading cause of maternal deaths especially in developing and under developed countries.
Poor uterine conditions, which include, failure of uterus to contract after childbirth is primarily the reason for post-partum hemorrhage and thus the demand for modern PPH treatment devices outpace the traditional methods as these devices aim towards healing the uterine conditions and problems of uterus contractions.
The growth of post-partum hemorrhage devices market is supported by a number of factors such as rise in incidence of PPH cases, increase in awareness regarding PPH risk factors, and increased pregnancy related complications.
Moreover, increase in number of education and training initiatives by the government on PPH has also propelled the growth of this market. However, lack of awareness in developing countries about the available devices and low adoption of PPH devices in these countries are expected to restrain the growth of the market.
The report segments the post-partum hemorrhage devices market on the basis of product type and geography. According to the product type, the market is segmented into Non-pneumatic anti-shock garment (NASG), Uniject prefilled injection system, and uterine balloon tamponade.
Uterine balloon tamponade is further segmented into Foley catheter Condom catheter, Bakri balloon tamponade, Rusch balloon and BT-Cath balloon. Geographical breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA.
Over the past few years, the key players have adopted product development (including product launches, approvals, and clinical trials) as their key developmental strategy. For instance, in July 2015, Inpress technologies completed and announced the successful completion of its first human trial for the device to control post-partum hemorrhage.
The trial was conducted on 10 patients to evaluate the efficiency of the device in controlling postpartum hemorrhage. The study generated significant results as the device on implantation into uterus was able to initiate hemorrhage control response within two minutes and attained full control on hemorrhage in just two hours on average.
Check Full Report With TOC@ www.researchbeam.com/post-partum-h…ge-devices-market
Category: Market Research Publishers and RetailersCompany about: We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. In order to survive the fierce competition and locate different avenues, one must be privy to high end and quality market information. So, we try and provide you with latest market information by getting high market research reports fro ...